Oral Busulfan and Cyclophosphamide (BU/CY) versus Cyclophosphamide, Melphalan and Vepsid (Etoposide) (CMV) with Autologous Stem Cell Transplant in Patients with Relapsed Non-Hodgkin Lymphomas (NHL)

DOI: 10.9734/IBRR/2017/35556

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text